Legal status by country
Is Tesamorelin / Ipamorelin legal?
Written by Aaron CuhaReviewed Sep 2026
How Tesamorelin / Ipamorelin is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Approved | Not approved | Not approved | Not approved |
| Classification | No approved blend; tesamorelin alone is approved as Egrifta | Not licensed | Not approved | Not approved |
| Note | Tesamorelin is FDA-approved for HIV-associated lipodystrophy. The blend is compounded or grey-market and has not been reviewed by the FDA for safety, purity or efficacy. | No licensed combination product. Unlicensed supply for human use is unlawful. | Both components are prohibited in sport by class (WADA S2). | Tesamorelin alone is approved by Health Canada as Egrifta; the blend is not. |
US FDA status: Not approved as a blend. Tesamorelin alone is FDA-approved as Egrifta for HIV-associated lipodystrophy; ipamorelin is not approved and no combination product exists.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.